An oligonucleotide is a short strand of nucleic acid, typically five to one hundred nucleotides long, in which nucleotide units are joined end to end through phosphodiester bonds. Depending on the sugar in each unit, the strand is either DNA, built on deoxyribose, or RNA, built on ribose. Despite this simple chemistry, oligonucleotides have become one of the most versatile tool kits in modern life science research, because their function rests on a single elegant principle: a strand recognizes and binds its complementary sequence through Watson-Crick base pairing, in which adenine pairs with thymine (or uracil in RNA) and guanine pairs with cytosine. This pairing is predictable from the sequence alone, which means that a researcher who knows a target sequence can, in principle, design a molecule that finds it inside a complex biological sample.
The word "types" in this context does not refer to a single formal classification. Instead, oligonucleotides are grouped by the role they play in an experiment, and each role imposes its own requirements on sequence design, chemical synthesis, and quality control. A useful way to organize the field is to sort oligonucleotides by their working mechanism:
Beyond sequence, chemical modification is the second axis that defines oligonucleotide types. Natural DNA and RNA are degraded rapidly by nucleases in serum and in cells, so most functional oligonucleotides carry deliberate chemical changes: phosphorothioate linkages in the backbone, 2′-O-methyl (2′-OMe) and 2′-fluoro (2′-F) sugars, locked nucleic acid (LNA) residues, or conjugates such as fluorophores, biotin, and peptides. These modifications, together with supporting monomer chemistry from nucleosides and nucleotides synthesis, determine how strongly a strand binds its target, how long it survives, and how it is detected. The sections that follow walk through each major oligonucleotide type in the same three-step order: how it is designed, how it is synthesized, and where it is used in research.
Table.1 Major Oligonucleotide Types at a Glance.
| Oligonucleotide Type | Typical Format | Working Principle | Representative Research Uses |
| DNA primers | Single-stranded DNA, 18-30 nt | Base pairing provides a starting point for polymerase extension | PCR, qPCR, sequencing, site-directed mutagenesis |
| Hybridization probes | Labeled DNA or RNA, 20-40 nt | Specific hybridization generates a detectable signal | qPCR detection, FISH, microarrays |
| Adapters and barcoded oligos | Partially double-stranded, indexed | Ligation attaches universal ends and sample indexes to library fragments | Next-generation sequencing library construction, multiplexing |
| Antisense oligonucleotides | Single-stranded, heavily modified, 16-20 nt | Binding to target RNA triggers cleavage or blocks processing | Transcript knockdown, splicing studies |
| siRNA duplexes | Double-stranded RNA, 19-21 bp with overhangs | RISC-mediated cleavage of complementary mRNA | Gene knockdown, pathway analysis |
| Aptamers | Single-stranded DNA or RNA, 25-100 nt | Three-dimensional folding binds non-nucleic acid targets | Binding assays, biosensors, affinity reagents |
| Guide RNAs | RNA, 20 nt spacer plus scaffold | Base pairing directs nucleases to genomic targets | Genome editing research, functional screens |
Primers are the workhorses of the oligonucleotide world. A primer is a short single-stranded DNA sequence that binds to a template strand and offers DNA polymerase a free 3′-hydroxyl group from which copying can begin. Every polymerase chain reaction, every sequencing read that starts from a known flank, and every site-directed mutagenesis experiment depends on primers behaving exactly as designed, which is why primer design remains one of the most taught and most refined skills in molecular biology.
The goal of primer design is a pair of sequences that bind only the intended target, melt at matched temperatures, and stay unstructured in solution. Specificity is anchored at the 3′ end: the last five to eight bases of a primer contribute disproportionately to stable binding, so a mismatch there prevents extension, while the 5′ end tolerates appended tails, restriction sites, and labels that do not participate in target recognition. Designers work through a short checklist for each candidate:
For demanding applications the checklist grows. Degenerate primers for conserved gene families mix bases at variable positions, but each added degeneracy dilutes the effective concentration of any single sequence, so degeneracy is capped near 1024-fold. Primers for allele-specific assays are deliberately placed so the discriminating nucleotide occupies the penultimate 3′ position, maximizing the penalty for a mismatched target.
Primers are made by solid-phase phosphoramidite synthesis, in which each nucleotide is added cycle by cycle to a growing chain tethered to a solid support. Coupling efficiency per cycle is high but not perfect, typically above 99%, so full-length yield falls as length increases: at 99.5% efficiency a 40-mer arrives roughly 82% full-length, while a 100-mer reaches only about 61%. This arithmetic drives practical synthesis decisions:
The application portfolio of primers spans nearly every nucleic acid workflow. In endpoint PCR, a primer pair amplifies a defined locus for cloning, genotyping, or gel-based analysis. In quantitative PCR, primer performance directly shapes the shape of amplification curves, so primer efficiency near 100% is verified with standard dilution series before any sample is interrogated. Sequencing workflows rely on universal and custom primers alike: Sanger sequencing uses a single primer flanking the region of interest, while targeted enrichment panels for next-generation sequencing use primer pools that tile across loci of interest. In site-directed mutagenesis, carefully offset primers carrying the desired substitution, insertion, or deletion amplify an entire circular template, and the parental template is removed afterward, allowing researchers to test the effect of precise sequence changes on protein function. Primer design also underpins synthetic biology, where long gene constructs are assembled from overlapping oligonucleotide sets, and genotyping assays, where allele-specific primers distinguish single-nucleotide variants.
From routine PCR pairs to labeled, degenerate, and ultra-long primers, our synthesis team delivers sequences with verified purity and matched performance.
If primers are the engine of amplification, probes are the eyes of detection. A hybridization probe is an oligonucleotide carrying a reporter unit, most often a fluorophore, that emits a signal only when the probe finds and binds its complementary target. Because signal generation is tied to hybridization itself, probes report the presence, quantity, and location of specific sequences with far greater confidence than intercalating dyes, which light up any double-stranded DNA in the tube.
A probe is only as good as its access to the target. Nucleic acids fold into secondary structures that can bury the region a probe aims at, so designers first screen the target sequence for strongly paired stems and choose accessible loops or single-stranded stretches. Specificity follows from length and chemistry: probes of 20-40 nucleotides bind their targets at temperatures well above those of spurious partial matches, and modified residues such as LNA raise binding stability further, allowing shorter probes that discriminate single-base differences cleanly. Key design considerations include:
Probe synthesis combines standard phosphoramidite chemistry with specialized labeling steps. In a hydrolysis probe for qPCR, a fluorophore sits at one end and a quencher at the other; during amplification, the 5′ nuclease activity of the polymerase physically separates the two dyes and releases fluorescence. Synthesis decisions cluster around the label set:
Peptide nucleic acid backbones push this logic further: because PNA probes are synthesized on a neutral amide backbone rather than a charged phosphodiester one, they bind complementary DNA or RNA with exceptional affinity and resist nuclease digestion entirely, properties explored in detail in our PNA synthesis service.
In quantitative PCR, hydrolysis probes convert each amplification event into a fluorescent increment, enabling precise quantification of gene expression, viral load, and copy number variation, and multiplex probe assays measure several targets in one tube through spectrally distinct dyes. Molecular beacons form an alternative probe format that fluoresces upon hybridization rather than cleavage, useful in isothermal amplification and in real-time monitoring of hybridization kinetics. In in situ hybridization, labeled probes bind nucleic acids directly inside fixed cells or tissue sections, revealing which cells in a mixed population carry a transcript, and where within the cell it accumulates. On microarrays, thousands of immobilized probes interrogate a labeled sample simultaneously, a format that remains valuable for targeted expression profiling and genotyping. Together these applications make probes the default choice whenever detection must be specific, quantitative, and attributable to a particular sequence.
Table.2 Common Probe Labeling Strategies and Their Detection Readouts.
| Labeling Strategy | How It Works | Typical Readout |
| Fluorophore + quencher pair | Polymerase cleavage or hybridization separates dye from quencher | Real-time fluorescence in qPCR and isothermal assays |
| Single fluorophore | Probe carries one dye detected after hybridization or capture | Microarray scanning, FISH imaging |
| Biotin | Streptavidin conjugates bind the labeled probe | Colorimetric or chemiluminescent detection, affinity capture |
| Hapten (digoxigenin-type) | Antibody reagents detect the hapten on the probe | Tissue and cell hybridization detection |
| LNA or MGB residues | Modified bases raise duplex stability, permitting shorter probes | Single-nucleotide variant discrimination |
We synthesize dual-labeled hydrolysis probes, molecular beacons, FISH probes, and LNA-enhanced sequences with rigorous dual HPLC purification.
Next-generation sequencing does not read raw DNA; it reads libraries, and libraries are built with oligonucleotides. Sequencing adapters are short, partly double-stranded constructs that are ligated onto the ends of fragmented DNA or cDNA. Once attached, they supply everything the sequencing instrument cannot get from the sample itself: sequences that anchor fragments to the flow cell, priming sites where sequencing polymerases initiate, and index barcodes that identify which sample each fragment came from. Because a single library preparation may involve dozens of adapter oligonucleotides working together, adapter quality has an outsized effect on data quality.
Adapter architecture reflects the competing needs of ligation chemistry and sequencing mechanics. In a typical Y-shaped adapter, one strand forms a double-stranded stem that ligates to the fragment and a single-stranded arm that later becomes the first sequencing cycle template, while the two strands carry different sequences so that read 1 and read 2 primers land on distinct sites. Design elements include:
Adapter synthesis is held to stricter standards than routine primer production, for two reasons. First, any truncated or unphosphorylated adapter that reaches a library competes for ligation and produces molecules that fail later steps, wasting sequencing capacity. Second, adapters work as annealed duplexes, so both component strands must be complete and present at exact stoichiometry. Production therefore emphasizes:
In whole-genome and targeted sequencing, adapters convert a heterogeneous population of fragments into a uniform, sequenceable library, and the same logic applies to RNA sequencing, where adapters are ligated to cDNA after reverse transcription, and to chromatin profiling assays, in which adapter-ligated fragments mark the genomic footprints of bound proteins. Multiplexing is the economic engine of modern sequencing: with indexed adapters, a dozen or more samples share one sequencing run, and index reads assign every fragment back to its sample afterward. UMIs add a quantitative layer, distinguishing true biological duplicates from PCR artifacts in applications such as rare-variant detection, single-cell sequencing, and transcript counting, where accurate molecule-level quantification matters. Well-designed adapter sets, including custom indexes for large panel studies, are therefore a quiet but decisive factor in the quality of sequencing data.
We supply index sets, UMI-bearing adapters, and custom duplex constructs with verified end chemistry and dual purification for consistent library yields.
Antisense oligonucleotides shift oligonucleotides from passive tools to active regulators of gene expression. An ASO is a single-stranded sequence, typically 16-20 nucleotides long, designed to bind a complementary segment of a target RNA inside the cell. Once bound, the ASO acts through one of two broad mechanisms: it either recruits a cellular enzyme to destroy the RNA, or it physically blocks the machinery that processes the RNA. Which mechanism operates is determined entirely by the ASO's chemistry, which makes chemical design the heart of antisense research.
RNase H-recruiting ASOs, known as gapmers, exploit a natural enzyme that recognizes RNA-DNA hybrids. The gapmer is built as a central window of 6-10 unmodified DNA nucleotides flanked on both sides by 2-5 chemically modified residues such as 2′-OMe, 2′-fluoro, or LNA. When the DNA window hybridizes to the target RNA, the resulting duplex is recognized by RNase H, which cleaves the RNA strand and releases the ASO to act again catalytically. Design considerations for gapmers include:
Steric-blocking ASOs take the opposite approach: they are fully modified, contain no DNA at all, and therefore never recruit RNase H. Instead, they occupy sites on the RNA that other proteins need. By binding across a splice site, a steric-blocking ASO prevents the spliceosome from recognizing that site, causing an exon to be skipped or included; by binding near the start codon or in the 5′ untranslated region, it can interfere with translation initiation; and by binding a leader sequence, it can interfere with processing of a viral or structural RNA. This splice-switching capability has made steric-blocking ASOs a favorite tool for studying isoform function, because researchers can ask what a cell does with, or without, a specific exon.
ASO synthesis is best understood as an evolution of chemistries assembled in layers. The first layer is the phosphorothioate (PS) backbone, in which one non-bridging oxygen of the phosphate is replaced by sulfur; this single change confers substantial nuclease resistance and improves interaction with plasma and cell-surface proteins. The second layer sits at the 2′ position of the sugar, where 2′-O-methyl and 2′-O-methoxyethyl groups raise duplex stability and further resist degradation, and 2′-fluoro substitution increases affinity markedly. The third layer includes conformationally restricted sugars such as LNA and constrained ethyl residues, which raise melting temperature by several degrees per substitution and enable very short, highly discriminating designs. Practical synthesis points include:
Table.3 Common ASO Chemical Modifications and Their Effects.
| Modification | Chemical Nature | Main Effect in ASOs |
| Phosphorothioate linkage | Sulfur replaces a non-bridging oxygen in the backbone | Nuclease resistance; improved protein binding and tissue distribution |
| 2′-O-methyl (2′-OMe) | Methyl group at the 2′ sugar position | Higher duplex stability; broad nuclease resistance; well tolerated in wings |
| 2′-O-methoxyethyl (2′-MOE) | Bulkier 2′ substituent | Strong affinity and stability gains for steric-blocking designs |
| 2′-fluoro (2′-F) | Fluorine at the 2′ sugar position | Large affinity increase; common in wings and siRNA strands |
| Locked nucleic acid (LNA) | Bridged sugar locks the ribose conformation | Highest per-residue affinity; enables short, mismatch-sensitive probes and gapmer wings |
In functional genomics, gapmer ASOs provide a rapid way to test what a gene does: when a transcript is knocked down and a phenotype follows, the connection between gene and function is supported in weeks rather than the months a knockout construct may require. ASO-mediated knockdown is particularly useful for targets where partial reduction is informative, such as dosage-sensitive genes, and for studying long non-coding RNAs, which often lack the clear coding frame that other perturbation strategies rely on. Splicing studies showcase the precision of steric-blocking ASOs: by masking specific splice signals, researchers can force exon skipping to model loss of a protein domain, promote inclusion of a Developmentally regulated exon, or shift isoform ratios and compare the functional output of each isoform. In RNA biology more broadly, ASOs serve as research tools for mapping RNA-protein interactions, isolating specific RNA species through complementary capture, and probing structural accessibility along a transcript.
Our chemists synthesize gapmers, splice-switching ASOs, and fully modified constructs with documented modification placement and HPLC-purified full-length product.
Small interfering RNAs harness one of the cell's own gene-silencing pathways. RNA interference (RNAi) is triggered when a double-stranded RNA of roughly 19-21 base pairs enters the cytoplasm and is loaded into the RNA-induced silencing complex (RISC). Within RISC, one strand, the guide, is retained and used to scan for complementary messenger RNA; when a near-perfect match is found, the argonaute protein at the core of RISC cleaves the target transcript. Synthetic siRNA simply delivers a ready-made duplex so that this pathway can be aimed at any gene a researcher chooses, making siRNA one of the fastest routes from sequence to loss-of-function data.
Effective siRNA design begins with choosing which strand of the duplex becomes the guide. RISC preferentially loads the strand whose 5′ end is less stably paired, a principle known as thermodynamic asymmetry, so designers arrange the duplex so the intended guide has the weaker 5′ end. Candidate sequences are then filtered through several screens:
Because single predictions remain imperfect, research programs typically design three to four independent siRNAs per gene and confirm that observed phenotypes reproduce with at least two of them, ideally alongside rescue experiments with a silencing-resistant construct.
siRNA is synthesized as two separate single strands that are purified individually and then annealed into the duplex, and each stage carries its own controls. Modern siRNA chemistry leans on the same 2′ modifications that serve ASOs, arranged asymmetrically:
We synthesize individually purified strands, anneal them under controlled conditions, and deliver RNase-free duplexes with documented modification patterns.
Aptamers break the base-pairing mold. An aptamer is a single-stranded DNA or RNA sequence, typically 25-100 nucleotides long, that folds into a compact three-dimensional shape, combining stems, loops, bulges, and sometimes G-quadruplex motifs, and presents a binding surface that grips a target molecule the way an antibody grips an antigen. Unlike every other oligonucleotide type in this article, aptamers recognize their targets by shape and charge complementarity rather than by sequence complementarity, which allows them to bind proteins, peptides, small molecules, ions, and even whole cells with high affinity and specificity.
Aptamers are not designed from first principles; they are selected. The dominant method, systematic evolution of ligands by exponential enrichment (SELEX), begins with a large random library, commonly 1013-1015 variants of a 20-40 nucleotide random region flanked by fixed primer-binding arms. The library is incubated with the target, sequences that bind are physically separated from those that do not, the bound fraction is amplified by PCR, and the cycle repeats under increasingly stringent conditions until a small family of high-affinity binders dominates the pool. Design considerations for the selected sequence include:
Chemical synthesis makes aptamers practical reagents: once a sequence is fixed, it can be produced consistently, which is difficult to guarantee for protein affinity reagents. Synthesis for aptamers emphasizes stability and labeling:
In the laboratory, aptamers substitute for antibodies across an expanding set of assays. They serve as capture and detection reagents in plate-based binding assays, as affinity ligands for pull-down and purification of their targets, and as staining reagents that report the location of targets in cells and tissues. A particularly active area is aptamer-based biosensors, where target binding changes a fluorescence resonance energy transfer signal, an electrochemical current, or a colorimetric readout in real time; because aptamers are small, chemically stable, and easy to modify at defined positions, they integrate into sensor surfaces more predictably than large protein reagents. In targeted delivery research, aptamers conjugated to other oligonucleotides guide siRNAs and ASOs toward cells that display the aptamer's target, a strategy explored further in our antibody-oligonucleotide conjugation service and related conjugate programs. Aptamers selected against small molecules also enable environmental and food-safety detection panels, where a chemically synthesized reagent with batch-to-batch consistency is a decisive advantage.
From truncated binding cores to nuclease-stabilized, multiply labeled constructs, we synthesize aptamers ready for folding, binding, and sensing workflows.
Guide RNAs are the addressing system of programmable genome editing. Nucleases such as Cas9 do not recognize DNA by themselves; they cut wherever the guide RNA tells them to. A guide RNA consists of a spacer, roughly 20 nucleotides complementary to the genomic target, fused to a scaffold region that folds into the shape the nuclease requires. When the complex finds a genomic sequence matching the spacer and sits next to a short protospacer-adjacent motif (PAM) recognized by the nuclease, the target strands are cut, and the cell's repair pathways then create insertions, deletions, or, with a donor template, precise sequence changes.
Guide design is a search problem with several simultaneous constraints. The spacer must match the target locus exactly, the locus must sit next to a PAM the chosen nuclease recognizes, and neither the spacer nor its close relatives may match anywhere else in the genome. Design checkpoints include:
Researchers can deploy guide RNAs in two formats, and synthesis follows the format. Two-part guides recreate the natural system from separate oligonucleotides: a CRISPR RNA (crRNA) carrying the spacer, typically 28-36 nucleotides total, and a trans-activating crRNA (tracrRNA), roughly 60-80 nucleotides, that pairs with it to form the scaffold. Because each part is short, both are amenable to full chemical synthesis with complete quality control. The single guide RNA (sgRNA) fuses spacer and scaffold into one molecule of about 100 nucleotides, which is at the practical limit of routine chemical synthesis but delivers a ready-to-use molecule with no annealing step. Production considerations for both formats include:
Guide RNAs power the full spectrum of genome-editing research. Paired with a nuclease and a donor template, they support precise sequence replacement studies in cell lines and model organisms, and without a donor they generate targeted disruptions whose repair outcomes reveal how cells process DNA breaks. Catalytically inactive nuclease fusions convert guides into targeting modules: fused to repressor domains they silence transcription, fused to activators they boost it, and fused to epigenetic-modifying enzymes they rewrite chromatin marks at chosen loci, all without cutting the DNA. At genome scale, pooled guide libraries enable functional genomics at breathtaking breadth: a library covering thousands of genes is introduced into a cell population, and the guides enriched or depleted after selection identify genes responsible for the selected phenotype. Such high-throughput screening campaigns have mapped gene essentiality, drug-resistance pathways, and regulatory networks, and each of these discoveries traces back to the quality of the guide oligonucleotides that drove the screen.
We synthesize chemically modified crRNAs, tracrRNAs, and full-length sgRNAs with PAGE or HPLC purification and consistent performance across batches.
Every oligonucleotide type described in this article places different demands on design, chemistry, purification, and analysis, and projects rarely fail at one single point; they fail quietly at the seams between these steps. BOC Sciences supports oligonucleotide research across all of those seams, from the first sequence sketch to the final analytical package, with synthesis capabilities spanning DNA, RNA, and the full landscape of modern modifications. Whether a project needs a handful of primers, a modified ASO series, duplexed siRNAs, or guide RNA libraries for a screen, our team structures the work around the molecule's intended use.
Our custom oligonucleotides synthesis service covers the complete design-to-delivery path. Scientists can submit finished sequences or work with our team to refine them: primer and probe designs are checked for secondary structure and melting behavior, ASO gapmers for modification placement and target accessibility, and siRNA pairs for strand asymmetry and seed-region concerns. On the synthesis side, we produce oligonucleotides from milligram to multi-gram scales with phosphorothioate backbones, 2′-OMe, 2′-MOE, and 2′-fluoro sugars, LNA residues, a broad selection of terminal and internal labels, and conjugation chemistry for peptides, sugars, and affinity tags. Unusual architectures, including duplex constructs, hairpins, and long sgRNAs near the limits of solid-phase synthesis, are routine work rather than special requests.
Purity requirements scale with the experiment, and we match the purification strategy to the application rather than applying one standard to everything. Desalted material serves routine amplification; reversed-phase and ion-exchange preparative HPLC remove truncations from labeled probes, ASOs, siRNAs, and guide RNAs; and PAGE purification is available for constructs where size resolution matters most. Every purified batch passes analytical confirmation before release:
Table.4 Oligonucleotide-Related Services at BOC Sciences.
| Service Name | Description | Inquiry |
| Custom Oligonucleotides Synthesis | Design and synthesis of DNA, RNA, and modified oligonucleotides including primers, probes, ASOs, siRNAs, and guide RNAs from research to larger scales. | Inquiry |
| Nucleosides & Nucleotides Synthesis | Custom synthesis of natural and modified nucleosides, nucleotides, and phosphoramidite building blocks supporting oligonucleotide programs. | Inquiry |
| PNA Synthesis | Synthesis of peptide nucleic acid oligomers with exceptional binding affinity and nuclease resistance for probes and antisense research. | Inquiry |
| Antibody-Oligonucleotide Conjugation Service | Site-aware conjugation of oligonucleotides to antibodies and proteins for targeted delivery, detection, and multifunctional reagent development. | Inquiry |
| Fluorescent Dye Labeling | Attachment of fluorophores across the visible and near-infrared spectrum to probes, aptamers, and other oligonucleotides for detection workflows. | Inquiry |
| Bioconjugation | Broad conjugation chemistry linking oligonucleotides to peptides, lipids, sugars, nanoparticles, and carrier proteins for expanded functionality. | Inquiry |
| MS Testing | Molecular weight confirmation and impurity characterization for oligonucleotide batches by mass spectrometry. | Inquiry |
Connect with our oligonucleotide specialists to discuss sequences, modifications, purification, and analytical support for your next project.
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.
